CDC warns of an imminent spike in COVID, flu cases
by
Contributor since / Followers
Contributor since / Followers
18 hours ago
angelp/iStock via Getty Images The Centers for Disease Control and Prevention (CDC) on Wednesday warned
BNTX
BioNTech started at buy, Moderna at hold by Berenberg
by
Contributor since / Followers
Contributor since / Followers
2 days ago
duoogle Berenberg has initiated coverage of BioNTech (NASDAQ:BNTX) and Moderna (NASDAQ:MRNA), citing their leadership positions
Vaccine stocks drop on concerns about RFK Jr. heading HHS (update)
by
Contributor since / Followers
Contributor since / Followers
6 days ago
Morsa Images Shares of several of the world’s largest vaccine makers fell significantly Friday, the
RFK and the ‘MAHA Trade’: Vaccine makers down, psychedelic shares up
by
Contributor since / Followers
Contributor since / Followers
6 days ago
Chip Somodevilla/Getty Images News After dropping off the campaign trail to join Team Trump, Robert
Vaccine makers close lower amid reports RFK Jr may head HHS
by
Contributor since / Followers
Contributor since / Followers
7 days ago
Morsa Images Shares of vaccine makers closed lower Thursday amid reports that President-elect Donald Trump
Merck to buy rights to Chinese cancer drug for up to $3.3B
by
Contributor since / Followers
Contributor since / Followers
1 week ago
Sundry Photography/iStock Editorial via Getty Images Merck (NYSE:MRK) and LaNova Medicines announced Thursday an agreement
BioNTech to buy bispecific antibody developer Biotheus for up to $950M
by
Contributor since / Followers
Contributor since / Followers
1 week ago
Maksim Labkouski BioNTech (NASDAQ:BNTX) said it has agreed to buy bispecific antibody developer Biotheus for
BioNTech upgraded to buy at Goldman Sachs on tumor asset
by
Contributor since / Followers
Contributor since / Followers
2 weeks ago
Victor Golmer/iStock Editorial via Getty Images Goldman Sachs has upgraded BioNTech (NASDAQ:BNTX) to buy citing
BioNTech Q3 Earnings Review: Good Quarter, Strong Promise — But Still A Hold
by Edmund Ingham
Contributor since 2018 / 12465 Followers
Contributor since 2018 / 12465 Followers
2 weeks ago
Summary: BioNTech SE’s stock saw a spike in September due to positive data from Summit
BioNTech reports Q3 results, reconfirms FY guidance
by
Contributor since / Followers
Contributor since / Followers
2 weeks ago
BioNTech press release (NASDAQ:BNTX): Q3 GAAP EPS of €0.81 Revenue of €1.2B (+34.0% Y/Y). Expects